Page 224 - 2019_01-Haematologica-web

214
haematologica | 2019; 104(1)
I. Marini et al. References
1 Rosenfeld BA, Herfel B, Faraday N, Fuller A, Braine H. Effects of storage time on quantitative and qualitative platelet func- tion after transfusion. Anesthesiology. 1995;83(6):1167-1172.
2 Brecher ME, Blajchman MA, Yomtovian R, Ness P, AuBuchon JP. Addressing the risk of bacterial contamination of platelets within the United States: a history to help illumi- nate the future. Transfusion. 2013; 53(1):221-231.
3 Dumont LJ, Gulliksson H, van der Meer PF, et al. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Transfusion. 2007;47(9): 1666-1673.
4 Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev. 1997;11 (2):130-144.
5 Capocelli KE, Dumont LJ. Novel platelet storage conditions: additive solutions, gas, and cold. Curr Opin Hematol. 2014;21(6): 491-496.
6 Devine DV, Serrano K. The platelet storage lesion. Clin Lab Med. 2010;30(2):475-487.
7 Currie LM, Harper JR, Allan H, Connor J. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4 degrees C with retention of in vitro functional activity. Transfusion. 1997;37(1):18-24.
8 Sandgren P, Hansson M, Gulliksson H, Shanwell A. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analy- sis of platelet glycoprotein expression. Vox Sang. 2007;93(1):27-36.
9 Reddoch KM, Pidcoke HF, Montgomery RK, et al. Hemostatic function of apheresis platelets stored at 4 degrees C and 22 degrees C. Shock. 2014;41 Suppl 1:54-61.
10 Pidcoke HF, Spinella PC, Ramasubramanian AK, et al. Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards. Shock. 2014;41 Suppl 1:51-53.
11 Montgomery RK, Reddoch KM, Evani SJ, Cap AP, Ramasubramanian AK. Enhanced shear-induced platelet aggregation due to low-temperature storage. Transfusion. 2013;53(7):1520-1530.
12 Lee DH, Blajchman MA. Novel treatment modalities: new platelet preparations and substitutes. Br J Haematol. 2001; 114(3):496-505.
13 Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell. 2003;112(1):87-97.
14 Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet via- bility--deleterious effect of refrigerated stor- age. N Engl J Med. 1969;280(20):1094-1098.
15 Pidcoke HF, McFaul SJ, Ramasubramanian AK, et al. Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion. 2013;53 Suppl 1:137S-149S.
16 Jobes D, Wolfe Y, O'Neill D, et al. Toward a definition of "fresh" whole blood: an in vitro characterization of coagulation prop- erties in refrigerated whole blood for trans- fusion. Transfusion. 2011;51(1):43-51.
17 Valeri CR. Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin-treated normal volun- teers. Transfusion. 1976;16(1):20-23.
18 Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T, Nelson E. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion. 2006;46(5):835-840.
19 Slichter SJ, Corson J, Jones MK, et al. Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Blood. 2014;123(2):271-280.
20 Hornsey VS, McColl K, Drummond O, et al. Extended storage of platelets in SSP platelet additive solution. Vox Sang. 2006; 91(1):41-46.
21 Thiele T, Pohler P, Kohlmann T, et al. Tolerance of platelet concentrates treated with UVC-light only for pathogen reduc- tion--a phase I clinical trial. Vox Sang. 2015; 109(1):44-51.
22 Bakchoul T, Fuhrmann J, Chong BH,
Bougie D, Aster R, Subcommittee on Platelet I. Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombo- cytopenia: communication from the SSC of the ISTH. J Thromb Haemost. 2015; 13(5):872-875.
23 Fuhrmann J, Jouni R, Alex J, et al. Assessment of human platelet survival in the NOD/SCID mouse model: technical considerations. Transfusion. 2016; 56(6):1370-1376.
24 Jansen AJ, Josefsson EC, Rumjantseva V, et al. Desialylation accelerates platelet clear- ance after refrigeration and initiates GPIbalpha metalloproteinase-mediated cleavage in mice. Blood. 2012;119(5):1263- 1273.
25 Wandall HH, Hoffmeister KM, Sorensen AL, et al. Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets. Blood. 2008;111(6): 3249-3256.
26 van der Wal DE, Du VX, Lo KS, Rasmussen JT, Verhoef S, Akkerman JW Platelet apop- tosis by cold-induced glycoprotein Ibalpha clustering. J Thromb Haemost. 2010; 8(11):2554-2562.
27 van der Wal DE, Verhoef S, Schutgens RE, Peters M, Wu Y, Akkerman JW Role of gly- coprotein Ibalpha mobility in platelet func- tion. Thromb Haemost. 2010;103(5):1033- 1043.
28 Chen W, Druzak SA, Wang Y, et al. Refrigeration-Induced Binding of von Willebrand Factor Facilitates Fast Clearance of Refrigerated Platelets. Arterioscler Thromb Vasc Biol. 2017;37(12):2271-2279.
29 Shiri R, Yari F, Ahmadinejad M, Vaeli S, Tabatabaei MR The caspase-3 inhibitor (peptide Z-DEVD-FMK) affects the survival and function of platelets in platelet concen- trate during storage. Blood Res. 2014; 49(1):49-53.
30 Slichter SJ, Bolgiano D, Corson J, et al. Extended storage of buffy coat platelet con- centrates in plasma or a platelet additive solution. Transfusion. 2014;54(9):2283- 2291.